Research plays a pivotal role in cancer care by finding better ways to prevent and treat cancer. Research also discovers ways and means to improve quality of life and extends survival for all who are diagnosed with cancer. In addition, research provides some patients with access to new, potentially more effective therapies, which are not otherwise available.
For over twenty years, our oncologists have participated in cancer research and clinical trials as a means to by updated with the latest developments and to attempt to provide patients with the best and most advanced possible care for their conditions.
We work closely with academic and professional institutions as well as with leading pharmaceutical and biotechnology companies in areas of chemotherapy and immunotherapy.
COT maintains powerful research infrastructure that includes specialized research staff, a dedicated Research Coordinator and a Patient Advocate. This highly efficient organization helps speed the process of bringing protocol drugs into patient care, while providing the highest quality care to our patients.
COT participates in clinical studies as well as translational research and epidemiological studies. Translational research is the type of study that looks into a patient’s tumor to find characteristics that may correlate with the patient’s response to therapy and prognosis. COT conducts its own translational research and also participates in several such studies both in Greece with the Hellenic Cooperative Oncology Group HeCOG, as well as with international groups such as the Breast International Group in Belgium, the Brain Tumors Founders Consortium, the European Organization for the Research and Treatment of Cancer and the Harvard University in the USA among others.
Besides translational research our physicians also participate in Phase II and III clinical trials that address all major solid tumor types and supportive care. Those are usually in collaboration with the aforementioned organizations and involve the study of new drugs or new combinations or known medications in new settings. These studies provide patients with access to new agents and a chance to contribute in the advancement of scientific knowledge.